Allogeneic NK cell transfusion

natural killer cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic NK cell transfusion, covering 2020-10-22 to 2020-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic NK Cell Transfusion Azacitidine MDS-EB [Phase 1, Phase 2]